These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15230292)

  • 1. Gene therapy in systemic lupus erythematosus.
    Kyttaris VC; Juang YT; Tsokos GC
    Lupus; 2004; 13(5):353-8. PubMed ID: 15230292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of biologicals for the therapy of lupus erythematosus.
    Neumann D; Tschernig T; Boraschi D
    Expert Rev Vaccines; 2007 Dec; 6(6):1001-11. PubMed ID: 18034656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunopathology and the gene therapy of lupus.
    Mageed RA; Prud'homme GJ
    Gene Ther; 2003 May; 10(10):861-74. PubMed ID: 12732872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stratification of pedigrees multiplex for systemic lupus erythematosus and for self-reported rheumatoid arthritis detects a systemic lupus erythematosus susceptibility gene (SLER1) at 5p15.3.
    Namjou B; Nath SK; Kilpatrick J; Kelly JA; Reid J; James JA; Harley JB
    Arthritis Rheum; 2002 Nov; 46(11):2937-45. PubMed ID: 12428235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct transfer of p65 into T lymphocytes from systemic lupus erythematosus patients leads to increased levels of interleukin-2 promoter activity.
    Herndon TM; Juang YT; Solomou EE; Rothwell SW; Gourley MF; Tsokos GC
    Clin Immunol; 2002 May; 103(2):145-53. PubMed ID: 12027419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncovering the genetics of systemic lupus erythematosus: implications for therapy.
    Kyttaris V; Tsokos G
    Am J Pharmacogenomics; 2003; 3(3):193-202. PubMed ID: 12814327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies.
    Lee HJ; Sinha AA
    Autoimmunity; 2006 Sep; 39(6):433-44. PubMed ID: 17060022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine mapping chromosome 16q12 in a collection of 231 systemic lupus erythematosus sibpair and multiplex families.
    Gillett CD; Langefeld CD; Williams AH; Ortmann WA; Graham RR; Rodine PR; Selby SA; Gaffney PM; Behrens TW; Moser KL
    Genes Immun; 2005 Feb; 6(1):19-23. PubMed ID: 15538391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging biological drugs: a new therapeutic approach for Systemic Lupus Erythematosus. An update upon efficacy and adverse events.
    Murdaca G; Colombo BM; Puppo F
    Autoimmun Rev; 2011 Nov; 11(1):56-60. PubMed ID: 21835271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy in systemic lupus erythematosus.
    Kyttaris VC; Sfikakis PP; Juang YT; Tsokos GC
    Curr Gene Ther; 2005 Dec; 5(6):677-84. PubMed ID: 16457656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic agents and innovative interventional approaches in the management of systemic lupus erythematosus.
    Strand V
    Curr Opin Rheumatol; 1999 Sep; 11(5):330-40. PubMed ID: 10503651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SLEB3 in systemic lupus erythematosus (SLE) is strongly related to SLE families ascertained through neuropsychiatric manifestations.
    Nath SK; Kelly JA; Reid J; Lam T; Gray-McGuire C; Namjou B; Aston CE; Harley JB
    Hum Genet; 2002 Jul; 111(1):54-8. PubMed ID: 12136236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SiLEncing SLE: the power and promise of small noncoding RNAs.
    Rigby RJ; Vinuesa CG
    Curr Opin Rheumatol; 2008 Sep; 20(5):526-31. PubMed ID: 18698172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory T cells in systemic lupus erythematosus.
    Ohl K; Tenbrock K
    Eur J Immunol; 2015 Feb; 45(2):344-55. PubMed ID: 25378177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
    J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The variation of T-cell clonal repertoire in patients with systemic lupus erythematosus (SLE) following autologous peripheral blood hematopoietic stem cell transplantation].
    Fu YW; Zhu P; Zhao XW; Li HF; Zeng ZZ; Zhang R; Wang YJ; Zhang Y; Liu JH
    Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(19):1648-52. PubMed ID: 14642095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined transplantation of autologous hematopoietic stem cells and allogenic mesenchymal stem cells increases T regulatory cells in systemic lupus erythematosus with refractory lupus nephritis and leukopenia.
    Wang Q; Qian S; Li J; Che N; Gu L; Wang Q; Liu Y; Mei H
    Lupus; 2015 Oct; 24(11):1221-6. PubMed ID: 25914407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biological therapies of systemic lupus erythematosus].
    Olesińska M; Chwalińska-Sadowska H; Mielnik P; Wiesik-Szewczyk E
    Pol Merkur Lekarski; 2006 Mar; 20(117):371-3. PubMed ID: 16780279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerogenic dendritic cells: role and therapeutic implications in systemic lupus erythematosus.
    Mok MY
    Int J Rheum Dis; 2015 Feb; 18(2):250-9. PubMed ID: 25639676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel tolerogenic peptide, hCDR1, for the specific treatment of systemic lupus erythematosus.
    Mozes E; Sharabi A
    Autoimmun Rev; 2010 Nov; 10(1):22-6. PubMed ID: 20659591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.